Neurofibromatosis

Reviewed by

Dr Andrew Mattin
MBBS | Accredited Orthopaedic Registrar

  • 1:3000 newborns
  • Equal in sex and race
  • NF 1 – longarm of chromosome 17
    • Gene product can be thought of as a tumor suppressor for cellular oncogene
    • A neural crest disorder
    • Cells migrate to parts of skin, brain, cord, nerves & adrenal glands
    • Von Recklinghausen disease. (1882)
    • Autosomal dominant disease. (Chromosome 17q11)
    • Gene that codes for neurofibromin.
  • NF 2 – Chromosome 22.( Schwannomin.)
    • Less common (1 in 50,000) but also autosomal dominant.
    • Mosaics of the 1 and 2 do not demonstrate orthopaedic manifestations

Classification

  • NF 1
    • 2 or more of – National Institute of Health Criteria.
      • at least 6 café au lait spots:
        • > 5mm in children,
        • > 15 mm in adults
      • 2 neurofibromas or 1 plexiform neurofibroma
      • freckling of the inguinal or axillary region
      • optical glioma
      • at least 2 lisch nodules (Iris condensations / hamartoma of the Iris)
      • a first degree relative with NF
      • a distinctive osseous lesion
        • sphenoid dysplasia
        • thinning of long bone cortex, with or without pseudarthrosis
  • NF 2
    • Bilateral acoustic neuromas
      • Bilateral vestibular schwannomas.
    • Paucity of peripheral findings
  • Diagnosis
    • may be delayed due to variable age of presentation of signs

Clinical

  • Café au lait spots – discrete tan spots
    • May take up to 1 year to appear
    • Smooth
    • Café au lait macules.
      • 99% have 6 or more that are >5cm in diameter by age of 1
      • Skin fold freckling. Axillary, inguinal, upper eye lids. 90% at 7 years
  • Neurofibroma
    • Cutaneous – benign schwann cells with fibrous tissue
    • Rapidly increasing numbers at puberty
    • >80% at 20 years
    • Plexiform neurofibromas
      • present at birth, highly infiltrative, darkly pigmented, limb gigantism or facial dysfigurement
      • prone to haemorrhage, pain, dysfiguration and malignant transformation.
      • 10-24%.
    • NF-1 lifetime risk of malignant transformation 5%.
  • Axillary or inguinal freckling
  • Optic pathway glioma
  • Neurological delayed development
  • HTN, CVA, congenital heart disease, vasculopathy.

Orthopaedic Manifestations

  • Unusual scoliosis
    • Scoliosis (Dystrophic, Non dystrophic)
  • Nonunion of a long bone
    • congenital pseudoarthrosis of the tibia
  • Overgrowth of a part
  • Soft tissue tumors

General

  • Osteopaenia complicates treatment
  • Osteomalacia,
  • Effects cellular growth of neural tissue

Spine

  • Spinal deformity. 49% patients.
    • intraspinal neurofibromatosis
    • Dystrophic changes.
    • Rib penciling,
    • Dumbbell lesions
    • Spindling of transverse process
    • vertebral wedging
    • foraminal enlargement
    • widened interpedicular distance
    • Dural ectasia
      • Circumferential dilation of the thecal sac and erodes surrouding bony structures.
      • Instability and deformity.
      • T2 MRI
    • Vertebral scalloping
      • Anterior and posterior vertebral scalloping
      • >3mm in thoracic spine, >4mm in lumbar spine.
      • Posterior is most common
      • 63% scalloped vertebrae have  associated dual ectasia or intraspinal neurofibroma.
    • Cervical spine
      • 30% of NF-1 patients.
      • Cervical kyphosis, rotatory subluxation, dysplastic changes.
      • More common in dysplastic curves.
      • Spondylolisthesis, spondyloptosis.
      • Many are asymptomatic.
    • Scoliosis
      • Dystrophic
        • Less common but more severe.
        • Short sharp angulated scoliosis.
        • Odd shaped vertebrae, codfish vertebrae
          • Scalloped posterior body
          • Eleveated neural foramen
          • Defective pedicles
          • Dural abnormality on MRI
          • Ribboned ribs
        • Relentless progression
        • Kyphosis common & can lead to neurologic dysfunction
      • Non dystrophic
        • Treat as idiopathic
        • Progresses at same rate as adolescent idiopathic scoliosis and same clinic appearance.
        • Earlier onset the worse prognosis.
        • Must monitor due to progression.
      • Management
        • All should be assessed with an MRI and CT.
          • Look for
            • Intra/extra spinal neoplasm.
          • Repeat if any rapid progression.
        • Treatment according to deformity
          • Observation <20°
          • Bracing 20-40°
          • Fusing >40°
        • Dystrophic scoliosis.
          • High risk of progression and neurological compromise.
          • Early and aggressive surgical intervention has been advocated to prevent dystrophic curve progression.
          • Bracing has not been effective.
          • 6 monthly monitoring <20°.
          • 20-40° surgery. 

Nonunion

  • May affect Tibia & fibula, radius, ulna, femur & clavicle
  • Congenital pseudoarthrosis of the tibia (CPT)
    • CPT 1 in 250,000 births.
    • 5% NF-1 have CPT.
    • Anterolateral bowing of tibia that presents in the first year of life.
    • Cortical thickening with narrowed intramedullary canal.
    • Spontaneous fracture followed by pseudarthrosis.
    • Treatment
      • Non operative.
        • Knee-ankle-foot orthosis to prevent fracture in dysplastic bone.
      • Operative
        • Principles
          • Variable union rates post operatively.
          • High refracture rate.
          • Common complication is non union, limb length discrepancy, refracture and valgus deformity.
        • Options
          • Bone grafting with IM fixation
            • Telescoping nails
          • EXFIX,
            • Ring external fixator
          • free vascularized fibular graft.
          • Resection of pseudarthrosis site.
          • Bone morphogenic proteins

Overgrowth

  • Any child with local gigantism has NF until proven otherwise
  • Overgrowth of some or all tissues in one region.
  • Unilateral segmental hypertrophy or gigantism.

Other lesions of bone:

  • Benign scalloping of the cortex
  • Cystic lesions
  • Permeative bone destruction

Malignancy

  • ~ 5%
  • usually CNS
  • neurofibrosarcoma can occur

Other

  • Lisch nodules
  • HTN secondary to renal artery stenosis
  • 50% have cognitive impairment
  • short big heads

Take home message

  • NF-1 autosomal dominant. 1 in 3,000.
  • Common orthopaedic manifestations which are challenging to manage.
  • Multidisciplinary approach is warranted as multi-organ involvement